Kynurenine pathway metabolites in humans: disease and healthy States.
about
Kynurenines in CNS disease: regulation by inflammatory cytokinesCurrent Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple SclerosisKynurenines in the mammalian brain: when physiology meets pathologyCharacterisation of the expression of NMDA receptors in human astrocytesBiochemical identification and crystal structure of kynurenine formamidase from Drosophila melanogasterThe kynurenine pathway activities in a sub-Saharan HIV/AIDS populationMetabolic Profiling of Systemic Lupus Erythematosus and Comparison with Primary Sjögren's Syndrome and Systemic SclerosisTargeted Deletion of Kynurenine 3-Monooxygenase in Mice: A NEW TOOL FOR STUDYING KYNURENINE PATHWAY METABOLISM IN PERIPHERY AND BRAINMetabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenineRole of the NMDA-receptor in Prepulse Inhibition in the Rat.Model of tryptophan metabolism, readily scalable using tissue-specific gene expression data.Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects.Tryptophan Metabolism in Patients With Chronic Kidney Disease Secondary to Type 2 Diabetes: Relationship to Inflammatory Markers.Plasma amino acids and metabolic profiling of dairy cows in response to a bolus duodenal infusion of leucine.Tryptophan Metabolism in Allergic DisordersEarly increase of plasma homocysteine in sepsis patients with poor outcomeFatigue in patients with lung cancer is related with accelerated tryptophan breakdown.Indoleamine 2,3 dioxygenase and metabolic control of immune responses.Mechanisms of the pellagragenic effect of leucine: stimulation of hepatic tryptophan oxidation by administration of branched-chain amino acids to healthy human volunteers and the role of plasma free tryptophan and total kynurenines.Indoleamine 2,3-dioxygenase 1 (ido1) is involved in the control of mouse caput epididymis immune environmentThe role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy - CTN PT006: study protocol for a randomized controlled trial.Interferon-γ-induced inflammatory markers and the risk of cancer: the Hordaland Health Study.Quinolinic acid toxicity on oligodendroglial cells: relevance for multiple sclerosis and therapeutic strategies.Age dependency of inhibition of alpha7 nicotinic receptors and tonically active N-methyl-D-aspartate receptors by endogenously produced kynurenic acid in the brainInduction of indoleamine 2,3-dioxygenase by Borrelia burgdorferi in human immune cells correlates with pathogenic potential.Liver Metabolic Alterations and Changes in Host Intercompartmental Metabolic Correlation during Progression of MalariaIndoleamine 2,3-dioxygenase in human hematopoietic stem cell transplantation.The antimicrobial activity of heterotrophic bacteria isolated from the marine sponge Erylus deficiens (Astrophorida, Geodiidae)Effect of oral administration of kynurenic acid on the activity of the peripheral blood leukocytes in miceIndoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing-Remitting Multiple Sclerosis.Expression of the Kynurenine Pathway in Human Peripheral Blood Mononuclear Cells: Implications for Inflammatory and Neurodegenerative DiseaseTryptophan Breakdown in Patients with HCV Infection is Influenced by IL28B Polymorphism.Improved separation and detection of picolinic acid and quinolinic acid by capillary electrophoresis-mass spectrometry: application to analysis of human cerebrospinal fluid.Kynurenic acid and 3-hydroxykynurenine production from D-kynurenine in mice.Effects of Exhaustive Aerobic Exercise on Tryptophan-Kynurenine Metabolism in Trained AthletesDifferential Transcriptome Networks between IDO1-Knockout and Wild-Type Mice in Brain Microglia and Macrophages.Tryptophan catabolism in Pseudomonas aeruginosa and potential for inter-kingdom relationship.The potential role of indoleamine 2,3 dioxygenase (IDO) as a predictive and therapeutic target for diabetes treatment: a mythical truth.Probiotic Supplements Beneficially Affect Tryptophan-Kynurenine Metabolism and Reduce the Incidence of Upper Respiratory Tract Infections in Trained Athletes: A Randomized, Double-Blinded, Placebo-Controlled Trial.Plasma Biomarkers of Inflammation, the Kynurenine Pathway, and Risks of All-Cause, Cancer, and Cardiovascular Disease Mortality: The Hordaland Health Study
P2860
Q21129356-F383CF26-D9C3-42B2-8D92-48491A2439F5Q26740330-3AD4DC45-5CCB-479D-8FB3-DB81EF8BCD54Q27003296-8FF9A734-6932-44C1-9FBD-FAFF53D19C35Q27316321-B1996654-41C0-4942-A7AF-7F62087C426BQ27681115-2DB70494-9928-44D2-924B-FE61BEE91F26Q28386378-8C28FD05-E99E-42AA-A1DA-CD831EBFB461Q28552792-34D500A1-91D8-4142-B60F-F8D955454710Q29306917-4FD42DDD-2EA3-458F-BD6C-3E57964E55E7Q30010622-AA40676F-D23F-4B4A-BDE2-D1852180BF51Q30472936-D75C0E03-2628-4FC3-8056-644837527824Q30678210-CA8ADE1A-8A13-4594-B8B9-EA33AE759C72Q33583816-CBDA9F80-8D89-4A73-8C31-21BD77220C2BQ33585122-94A6F993-1D89-4CA0-94FE-A550160E30D8Q33615740-F76CACDE-28B0-486B-92D4-0D2E0E0ED85FQ33693287-271EFA28-4BD6-4FA6-8CC8-539347A1AB0DQ34274236-34586CA3-8230-47EB-8A8D-D0213AD7EBCFQ34277561-6F0A5330-EC2F-4D88-85D8-C4BD4FD75A8CQ34308495-8C6E5A50-E0FD-4255-B8EB-7C0A188085DAQ34454523-7D3C4000-4754-42E6-9FCF-4513AF298493Q34805596-F8DA2C62-12EA-4FC2-9FD0-D292B6865E0EQ34812071-2302184D-A5E0-4061-8DC1-6886FAABA1CAQ34819340-334CD0E1-2D04-48D8-9183-3AAFAC21B7E4Q34997869-1ABA452E-780D-4BD3-A3B8-E1B1DFC0AC47Q35003093-9A3699D7-A5E4-41C8-B913-87B5317B930AQ35005881-7B5792C4-3D8B-42E1-88A5-141DEECDE1B7Q35101615-94CB04B1-6446-4220-B460-D557089F16BFQ35366857-51AD8DE4-B9B5-4A4F-BA20-7CA2DED09B72Q35580082-2C152C43-E324-42E4-B64B-B4694B707649Q35631721-B4FFF9EE-C2DE-43C5-8FDA-09A1B3B23426Q35674541-A17DA31A-E37D-4A17-82A5-064D788F14E6Q35788146-6AC360DD-5B7F-4A0E-A9BE-A6DDD1386729Q35818383-D612A502-5143-47C4-81D4-E68B653283B9Q35852039-575C0BE1-6CEB-4D28-BC0B-A8FC4EE46817Q35923160-CA27D622-0597-4EAE-A82D-CAD6955C6334Q36002082-F2F7EE21-9F24-4558-84DA-175D6BC0C1AFQ36055343-F0009E70-E784-4B62-A72F-87982D37771DQ36071762-2B50C656-3D39-4343-B1DA-00B9F3A90B14Q36117580-1BEC8B61-555A-4AF1-B3C5-A0237DD10978Q36203906-311AB0C4-FC51-4445-A9CF-4D4B84F39782Q36579036-8300434B-D200-4B40-8F43-486A7AC60D2E
P2860
Kynurenine pathway metabolites in humans: disease and healthy States.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Kynurenine pathway metabolites in humans: disease and healthy States.
@ast
Kynurenine pathway metabolites in humans: disease and healthy States.
@en
Kynurenine pathway metabolites in humans: disease and healthy States.
@nl
type
label
Kynurenine pathway metabolites in humans: disease and healthy States.
@ast
Kynurenine pathway metabolites in humans: disease and healthy States.
@en
Kynurenine pathway metabolites in humans: disease and healthy States.
@nl
prefLabel
Kynurenine pathway metabolites in humans: disease and healthy States.
@ast
Kynurenine pathway metabolites in humans: disease and healthy States.
@en
Kynurenine pathway metabolites in humans: disease and healthy States.
@nl
P2860
P1476
Kynurenine pathway metabolites in humans: disease and healthy States.
@en
P2093
Gilles J Guillemin
Yiquan Chen
P2860
P577
2009-01-08T00:00:00Z